Apple’s products are now seen as status symbols, particularly in Tier 2 and ... Partnerships with manufacturers like Foxconn, Pegatron, and Jabil signify Apple's dedication to creating a robust ...

Meanwhile, Jabil’s market share has declined slightly from 5.3% in 2027 to 4.9% in 2024. We noted that Jabil’s revenue in 2024 has experienced the highest decline among competitors ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances ...

The latest trading session saw Jabil (JBL) ending at $162.64, denoting a +1.03% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily gain of 0.53%.

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with a transaction set to propel the company into the CDMO market.

Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to announce this acquisition. With our shared commitment to creating the best ...

Jabil Inc. closed 7.48% below its 52-week high of $174.80, which the company reached on January 24th.

The stock's fall snapped an eight-day winning streak.

Headquartered in St. Petersburg, FL, Jabil, Inc. is one of the largest global suppliers of electronic manufacturing services. The company offers electronics design, production, product management ...